Keywordsoveractive bladder, urinary urgency, micturition diary
Urinary incontinence is a problem among both older and young women. The most common symptoms of this condition include urinary incontinence and an unpleasant odour. In order to conceal the ailments related to this problem, women change their lifestyle by limiting the amount of fluid consumed and not moving too far from home or places where toilets are located. The main source of information on this disease in women aged over 45 is books, magazines and websites. Medical personnel are only ranked behind them. In order to make a correct diagnosis of this disease and to start treatment, urodynamic examination, urinalysis, cystoscopy and imaging examinations should be performed. Urodynamic examination can be divided into two groups: invasive and non-invasive. The micturition diary is considered to be the basic urodynamic test. It allows for performing differential diagnosis of functional micturition disorders. It is characterized by high repeatability and correlation with clinical symptoms. Treatment options are dependent on the type of urinary incontinence. They may include conservative treatment, surgery and pharmacotherapy. Combining conservative methods with pharmacological or surgical methods brings the most beneficial results. Invasive methods are the last-line therapy.
Radziszewski P. Nietrzymanie moczu – poradnik. SMPC, Warszawa 2014.
Coyne KS, Sexton CC, Irwin DE, et al. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 2008; 101: 1388-95.
. Radziszewski P, Dobroński P. Nietrzymanie moczu. Wydawnictwo Lekarskie PZWL, Warszawa 2008.
Prajsner, A. Techniki badań urodynamicznych: pułapki techniczne i trudności interpretacyjne wyników–część I. Urolaogii Polska 2008/61/3.
Jozwik M. The physiological basis of pelvic floor exercises in the treatment of stress urinary incontinence. Br J Obstet Gynaecol 1998;105:1046-1051. ??
. Altman D, Forsman M, Falconer C, et al. Genetic influence on stress urinary incontinence and pelvic organ prolapse. Eur Urol 2008;54(4):918-22. Epub 2007 Dec 17.
Rohr G., Kragstrup J, Gaist D, et al. Genetic and environmental influences on urinary incontinence: a Danish population-based twin study of middle-aged and elderly women. Acta Obstet Gynecol Scand 2004;83(10):978-82.
Intersdyscyplinarne wytyczne Polskiego Towarzystwa Uroginekologicznego odnośnie diagnostyki i leczenia obniżenia narządów miednicy mniejszej https://ptug.pl/algorytmy-postepowania/intersdyscyplinarne-wytyczne-polskiego-towarzystwa-uroginekologicznego-odnosnie-diagnostyki-i-leczenia-obnizenia-narzadow-miednicy-mniejszej/
Pool-Goudzwaard A, van Dijke GH, van Gurp M, Mulder P, Snijders C, Stoeckart R. Contribution of pelvic floor muscles to stiffness of the pelvic ring. Clin Biomech (Bristol, Avon). 2004 Jul;19(6):564-71. doi: 10.1016/j.clinbiomech.2004.02.008. PMID: 15234479.
Jóźwik M, Jóźwik M. The physiological basis of pelvic floor exercises in the treatment of stress urinary incontinence. Br J Obstet Gynaecol. 1998 Oct;105(10):1046-51. PMID: 9800925.
Kobelt-Nguyen G, Johannesson M, Mattiasson A, et al. Correlations between symptoms of urge incontinence and scores of a generic quality of life instrument (SF36) and health status measurements (EuroQoL) and between changes in symptoms and QoL scores. Presented at 27th Annual Meeting of the International Continence Society (ICS); 1997 Sep 23–27; Yokohama
Kobelt G, Kirchberger I, Malone-Lee J. Review. Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine. BJU Int. 1999 Apr;83(6):583-90. doi: 10.1046/j.1464-410x.1999.00004.x. PMID: 10233562.
Hashim, H., Abrams, P. Drug Treatment of Overactive Bladder. Drugs 64, 1643–1656 (2004). https://doi.org/10.2165/00003495-200464150-00003
Liberman JN, Hunt TL, Stewart WF, Wein A, Zhou Z, Herzog AR, Lipton RB, Diokno AC. Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey. Urology. 2001 Jun;57(6):1044-50. doi: 10.1016/s0090-4295(01)00986-4. PMID: 11377301.
Anger JT, Weinberg A, Suttorp MJ, Litwin MS, Shekelle PG. Outcomes of intravesical botulinum toxin for idiopathic overactive bladder symptoms: a systematic review of the literature. J Urol 2010;183:2258–64
Arnold J., McLeod N., Thani-Gasalam R., Rashid P. Overactive bladder syndrome: Management and treatment options. Australian family physician 2012. 41. 878-83.
Chapple, C.R. and Bryan, N.P. (1998) Surgery for detrusor overactivity. World J Urol 16: 268273.
Foon R, Drake MJ. The overactive bladder. Ther Adv Urol. 2010 Aug;2(4):147-55. doi: 10.1177/1756287210373757. PMID: 21789091; PMCID: PMC3126078.
Swami, K.S., Feneley, R.C., Hammonds, J.C. and Abrams, P. (1998) Detrusor myectomy for detrusor overactivity: a minimum 1-year follow-up. Br J Urol 81: 6872.
How to Cite
LicenseThe periodical offers access to content in the Open Access system under the Creative Commons non-exclusive license (CC BY-ND 4.0).
Number of views and downloads: 34
Number of citations: 0